Published in Vaccine Weekly, February 21st, 2007
The Digene direct-to-consumer campaign is designed to educate women about the benefits of testing for the human papillomavirus (HPV) as part of cervical cancer prevention. The Digene HPV Test is the only FDA-approved test for high-risk types of HPV, and is approved for use along with a Pap test to screen women age 30 and older - the group most at risk of cervical cancer.
"We have proven...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly